Risk Evaluation and Mitigation Strategies (REMS)

Risk Evaluation and Mitigation Strategies (REMS)

REMS are requirements set by the Food and Drug Administration (FDA) for pharmaceutical manufacturers to help ensure that the benefits outweigh the risks for certain drugs. There are several components of REMS that can be used by the pharmaceutical industry, including one or more of the following:
Medication Guides or Patient Package Inserts
FDA-approved instructions for appropriate use and instructions for patients focused on avoiding serious adverse events
Communication Plans

To read more, please click this link:


Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s